Timber Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
September 11 2020 - 4:30PM
via NewMediaWire-- Timber Pharmaceuticals, Inc. ("Timber" or the
“Company”) (NYSE American: TMBR), a biopharmaceutical company
focused on the development and commercialization of treatments for
orphan dermatologic diseases, today announced that it will be
presenting at the H.C. Wainwright 22nd Annual Global Investment
Conference being held virtually from September 14-16, 2020.
Timber’s presentation is scheduled for Wednesday, September 16th at
12:30 PM ET.
John Koconis, Chief Executive Officer of Timber,
will be presenting a corporate overview to a live audience and will
be available for virtual one-on-one meetings with investors
throughout the conference.
The online presentation will be webcast live and can be accessed
by following this link:
https://wsw.com/webcast/hcw7/tmbr/1614541
About Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. is a
biopharmaceutical company focused on the development and
commercialization of treatments for orphan dermatologic diseases.
The Company's investigational therapies have proven
mechanisms-of-action backed by decades of clinical experience and
well-established CMC (chemistry, manufacturing and control) and
safety profiles. The Company is initially focused on developing
non-systemic treatments for rare dermatologic diseases including
congenital ichthyosis (CI), facial angiofibromas (FAs) in tuberous
sclerosis complex (TSC), and localized scleroderma. For more
information, visit www.timberpharma.com.
For more information, contact:
Timber Pharmaceuticals, Inc. John Koconis Chief Executive
Officer jkoconis@timberpharma.com
Investor Relations: Stephanie Prince PCG Advisory (646) 762-4518
sprince@pcgadvisory.com
Media Relations: Adam Daley Berry & Company Public Relations
(212) 253-8881 adaley@berrypr.com
Timber Pharmaceuticals (AMEX:TMBR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Timber Pharmaceuticals (AMEX:TMBR)
Historical Stock Chart
From Apr 2023 to Apr 2024